StonvexLoading…
StonvexStonvexStonvexCore line items from EEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $463.40M | $398.80M | $382.80M | $325.90M |
Operating Income | $22.50M | $46.80M | $34.70M | $179.80M |
Net Income | $-30.70M | $2.20M | $-8.20M | $130.80M |
EPS (Diluted) | $-0.15 | $-0.07 | $-0.78 | $0.46 |
Total Assets | $1.21B | $1.05B | $1.05B | $1.10B |
Total Liabilities | $874.00M | $662.80M | $649.30M | $659.10M |
Cash & Equivalents | $100.90M | $194.80M | $204.20M | $239.10M |
Free Cash Flow OCF − CapEx | $41.40M | $45.50M | $39.70M | $173.30M |
Shares Outstanding | 197.70M | 201.45M | 62.91M | 67.59M |